Early detection, accurate segmentation, classification and tracking of polyps during colonoscopy are critical for preventing colorectal cancer. Many existing deep-learning-based methods for analyzing colonoscopic videos either require task-specific fine-tuning, lack tracking capabilities, or rely on domain-specific pre-training. In this paper, we introduce PolypSegTrack, a novel foundation model that jointly addresses polyp detection, segmentation, classification and unsupervised tracking in colonoscopic videos. Our approach leverages a novel conditional mask loss, enabling flexible training across datasets with either pixel-level segmentation masks or bounding box annotations, allowing us to bypass task-specific fine-tuning. Our unsupervised tracking module reliably associates polyp instances across frames using object queries, without relying on any heuristics. We leverage a robust vision foundation model backbone that is pre-trained unsupervisedly on natural images, thereby removing the need for domain-specific pre-training. Extensive experiments on multiple polyp benchmarks demonstrate that our method significantly outperforms existing state-of-the-art approaches in detection, segmentation, classification, and tracking.

Its noninvasive nature and sensitivity to absorption related to tissue biomolecular content and scattering change, associated with subcellular morphology, make it an extremely powerful tool to analyse tissue composition, microstructure or oxygenation status, offering promising performance in applications such as cancer diagnostics and surgical guidance [1, 30, 85, 121]. DRS signals are measured by delivering a typically white light source into the tissue and detecting diffusely reflected signals at a certain distance from the source, where the distance between the emitting and receiving fibres determines the tissue depth probed. Depending on the application and clinical objective, multiple illumination or detection fibres can be used to obtain more quantitative information and probe different depths. The light delivery and collection from tissue are often handled using optical fibres or fibre bundles. When incident on the tissue, the light undergoes scattering and absorption processes, which alter the light intensity across the measured spectrum [75, 121].

High-resolution colon segmentation is crucial for clinical and research applications, such as digital twins and personalized medicine. However, the leading open-source abdominal segmentation tool, TotalSegmentator, struggles with accuracy for the colon, which has a complex and variable shape, requiring time-intensive labeling. Here, we present the first fully automatic high-resolution colon segmentation method. To develop it, we first created a high resolution colon dataset using a pipeline that combines region growing with interactive machine learning to efficiently and accurately label the colon on CT colonography (CTC) images. Based on the generated dataset consisting of 435 labeled CTC images we trained an nnU-Net model for fully automatic colon segmentation. Our fully automatic model achieved an average symmetric surface distance of 0.2 mm (vs. 4.0 mm from TotalSegmentator) and a 95th percentile Hausdorff distance of 1.0 mm (vs. 18 mm from TotalSegmentator). Our segmentation accuracy substantially surpasses TotalSegmentator. We share our trained model and pipeline code, providing the first and only open-source tool for high-resolution colon segmentation. Additionally, we created a large-scale dataset of publicly available high-resolution colon labels.

Colorectal cancer (CRC) is a significant global health concern, and early detection through screening plays a critical role in reducing mortality. While deep learning models have shown promise in improving polyp detection, classification, and segmentation, their generalization across diverse clinical environments, particularly with out-of-distribution (OOD) data, remains a challenge. Multi-center datasets like PolypGen have been developed to address these issues, but their collection is costly and time-consuming. Traditional data augmentation techniques provide limited variability, failing to capture the complexity of medical images. Diffusion models have emerged as a promising solution for generating synthetic polyp images, but the image generation process in current models mainly relies on segmentation masks as the condition, limiting their ability to capture the full clinical context. To overcome these limitations, we propose a Progressive Spectrum Diffusion Model (PSDM) that integrates diverse clinical annotations-such as segmentation masks, bounding boxes, and colonoscopy reports-by transforming them into compositional prompts. These prompts are organized into coarse and fine components, allowing the model to capture both broad spatial structures and fine details, generating clinically accurate synthetic images. By augmenting training data with PSDM-generated samples, our model significantly improves polyp detection, classification, and segmentation. For instance, on the PolypGen dataset, PSDM increases the F1 score by 2.12% and the mean average precision by 3.09%, demonstrating superior performance in OOD scenarios and enhanced generalization.

Deep learning techniques are increasingly being adopted in diagnostic medical imaging. However, the limited availability of high-quality, large-scale medical datasets presents a significant challenge, often necessitating the use of transfer learning approaches. This study investigates self-supervised learning methods for pre-training capsule networks in polyp diagnostics for colon cancer. We used the PICCOLO dataset, comprising 3,433 samples, which exemplifies typical challenges in medical datasets: small size, class imbalance, and distribution shifts between data splits. Capsule networks offer inherent interpretability due to their architecture and inter-layer information routing mechanism. However, their limited native implementation in mainstream deep learning frameworks and the lack of pre-trained versions pose a significant challenge. This is particularly true if aiming to train them on small medical datasets, where leveraging pre-trained weights as initial parameters would be beneficial. We explored two auxiliary self-supervised learning tasks, colourisation and contrastive learning, for capsule network pre-training. We compared self-supervised pre-trained models against alternative initialisation strategies. Our findings suggest that contrastive learning and in-painting techniques are suitable auxiliary tasks for self-supervised learning in the medical domain. These techniques helped guide the model to capture important visual features that are beneficial for the downstream task of polyp classification, increasing its accuracy by 5.26% compared to other weight initialisation methods.

Deep learning methods have demonstrated strong performance in objection tasks; however, their ability to learn domain-specific applications with limited training data remains a significant challenge. Transfer learning techniques address this issue by leveraging knowledge from pre-training on related datasets, enabling faster and more efficient learning for new tasks. Finding the right dataset for pre-training can play a critical role in determining the success of transfer learning and overall model performance. In this paper, we investigate the impact of pre-training a YOLOv8n model on seven distinct datasets, evaluating their effectiveness when transferred to the task of polyp detection. We compare whether large, general-purpose datasets with diverse objects outperform niche datasets with characteristics similar to polyps. In addition, we assess the influence of the size of the dataset on the efficacy of transfer learning. Experiments on the polyp datasets show that models pre-trained on relevant datasets consistently outperform those trained from scratch, highlighting the benefit of pre-training on datasets with shared domain-specific features.

Trustworthiness is essential for the precise and interpretable application of artificial intelligence (AI) in medical imaging. Traditionally, precision and interpretability have been addressed as separate tasks, namely medical image analysis and explainable AI, each developing its own models independently. In this study, for the first time, we investigate the development of a unified medical vision-language pre-training model that can achieve both accurate analysis and interpretable understanding of medical images across various modalities. To build the model, we construct MedConcept-23M, a large-scale dataset comprising 23 million medical image-text pairs extracted from 6.2 million scientific articles, enriched with concepts from the Unified Medical Language System (UMLS). Based on MedConcept-23M, we introduce ConceptCLIP, a medical AI model utilizing concept-enhanced contrastive language-image pre-training. The pre-training of ConceptCLIP involves two primary components: image-text alignment learning (IT-Align) and patch-concept alignment learning (PC-Align). This dual alignment strategy enhances the model's capability to associate specific image regions with relevant concepts, thereby improving both the precision of analysis and the interpretability of the AI system. We conducted extensive experiments on 5 diverse types of medical image analysis tasks, spanning 51 subtasks across 10 image modalities, with the broadest range of downstream tasks. The results demonstrate the effectiveness of the proposed vision-language pre-training model. Further explainability analysis across 6 modalities reveals that ConceptCLIP achieves superior performance, underscoring its robust ability to advance explainable AI in medical imaging. These findings highlight ConceptCLIP's capability in promoting trustworthy AI in the field of medicine.

Artificial intelligence (AI) has potential to revolutionize the field of oncology by enhancing the precision of cancer diagnosis, optimizing treatment strategies, and personalizing therapies for a variety of cancers. This review examines the limitations of conventional diagnostic techniques and explores the transformative role of AI in diagnosing and treating cancers such as lung, breast, colorectal, liver, stomach, esophageal, cervical, thyroid, prostate, and skin cancers. The primary objective of this paper is to highlight the significant advancements that AI algorithms have brought to oncology within the medical industry. By enabling early cancer detection, improving diagnostic accuracy, and facilitating targeted treatment delivery, AI contributes to substantial improvements in patient outcomes. The integration of AI in medical imaging, genomic analysis, and pathology enhances diagnostic precision and introduces a novel, less invasive approach to cancer screening. This not only boosts the effectiveness of medical facilities but also reduces operational costs. The study delves into the application of AI in radiomics for detailed cancer characterization, predictive analytics for identifying associated risks, and the development of algorithm-driven robots for immediate diagnosis. Furthermore, it investigates the impact of AI on addressing healthcare challenges, particularly in underserved and remote regions. The overarching goal of this platform is to support the development of expert recommendations and to provide universal, efficient diagnostic procedures. By reviewing existing research and clinical studies, this paper underscores the pivotal role of AI in improving the overall cancer care system. It emphasizes how AI-enabled systems can enhance clinical decision-making and expand treatment options, thereby underscoring the importance of AI in advancing precision oncology

Survival prognosis is crucial for medical informatics. Practitioners often confront small-sized clinical data, especially cancer patient cases, which can be insufficient to induce useful patterns for survival predictions. This study deals with small sample survival analysis by leveraging transfer learning, a useful machine learning technique that can enhance the target analysis with related knowledge pre-learned from other data. We propose and develop various transfer learning methods designed for common survival models. For parametric models such as DeepSurv, Cox-CC (Cox-based neural networks), and DeepHit (end-to-end deep learning model), we apply standard transfer learning techniques like pretraining and fine-tuning. For non-parametric models such as Random Survival Forest, we propose a new transfer survival forest (TSF) model that transfers tree structures from source tasks and fine-tunes them with target data. We evaluated the transfer learning methods on colorectal cancer (CRC) prognosis. The source data are 27,379 SEER CRC stage I patients, and the target data are 728 CRC stage I patients from the West China Hospital. When enhanced by transfer learning, Cox-CC's $C^{td}$ value was boosted from 0.7868 to 0.8111, DeepHit's from 0.8085 to 0.8135, DeepSurv's from 0.7722 to 0.8043, and RSF's from 0.7940 to 0.8297 (the highest performance). All models trained with data as small as 50 demonstrated even more significant improvement. Conclusions: Therefore, the current survival models used for cancer prognosis can be enhanced and improved by properly designed transfer learning techniques. The source code used in this study is available at https://github.com/YonghaoZhao722/TSF.

In many modern applications from, for example, bioinformatics and computer vision, samples have multiple feature representations coming from different data sources. Multiview learning algorithms try to exploit all these available information to obtain a better learner in such scenarios. In this paper, we propose a novel multiple kernel learning algorithm that extends kernel k-means clustering to the multiview setting, which combines kernels calculated on the views in a localized way to better capture sample-specific characteristics of the data. We demonstrate the better performance of our localized data fusion approach on a human colon and rectal cancer data set by clustering patients. Our method finds more relevant prognostic patient groups than global data fusion methods when we evaluate the results with respect to three commonly used clinical biomarkers.